Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Tintina Mines Ltd TNNTF


Primary Symbol: V.TTS

Metals & Mining Industrial Metals & Minerals
Tintina Mines Limited is a junior mining company. The Company focuses on the acquisition, exploration and development of base and precious metals properties in Canada and Chile. Its principal assets include the Red Mountain molybdenum deposits located in the Whitehorse Mining District in Yukon and the Watson Lake project in the southeastern of the Yukon Territory. The Watson Lake Project is... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:TTS)

Tintina Mines Engages SRK Consulting to Update the National Instrument 43-101 Technical Report for the Domeyko Sulfuros Project, Chile

GlobeNewswire November 12, 2024

Tintina Announces Resignation of Director and Appointment of New Director

GlobeNewswire October 18, 2024

Tintina Mines Limited Announces 2024 Exploration Plan for the Domeyko Sulfuros Project

GlobeNewswire September 16, 2024

Tintina Announces Continuance to British Columbia

GlobeNewswire September 10, 2024

Tintina Announces Closing of Investment in Chile and Debt Reorganization

GlobeNewswire August 14, 2024

Canadian Investment Regulatory Organization Trade Resumption - TTS

Canada NewsWire August 12, 2024

Tintina Announces Share Consolidation

GlobeNewswire August 8, 2024

Tintina Provides Additional Information Relating to Proposed Investment in Chile and Debt Reorganization

GlobeNewswire June 17, 2024

Tintina Announces Investment in Chile and Debt Reorganization

GlobeNewswire February 6, 2024
View More News ››

Opinion & Analysis (TSXV:TTS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:TTS)

5 nr since August 1

eom
TELEMARKER - October 27, 2024

news

TORONTO, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Tintina Mines Limited (“Tintina” or the “Company”) (TSXV: TTS) is pleased to announce that...
TELEMARKER - February 13, 2024

RE:Tintina Announces Execution of Royalty Repurchase Agreement

this@ is substantial, TTS getting $7 million 43 millionb shares outstanding
TELEMARKER - June 1, 2022

Tintina Announces Execution of Royalty Repurchase Agreement

TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- Tintina Mines Limited (“Tintina” or the “Company”) (TSX VENTURE: TTS) is pleased to...
Betteryear2 - March 28, 2022

MD&A Dec 31 2015

As at December 31, 2015, the Company had a working capital deficiency of $11,210,928 [December 31, 2014 - $11,104,094] which included a...
TELEMARKER - May 7, 2016

Trading summary

Close Prices Last 3 Months Price/volumes not adjusted for restructures Date ...
TELEMARKER - April 18, 2016
View more Bullboard ››

NurExone Biologic Inc.

NurExone Biologic Inc.

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ...
View More »